Combining DNA Cancer Vaccines with Checkpoint Inhibitors to Induce an Immune Response in the Tumor & Have a Positive Patient Response
Time: 2:30 pm
day: Conference Day One
Details:
- Enhancing the efficacy of DNA cancer vaccines using checkpoint inhibitors as standard of care to induce a strong immune response
- Exploring self-adjuvanted therapies with personalized cancer vaccines for best patient response
- Employing a double-edged sword of checkpoint inhibitors and the high peptide capability of DNA-based cancer vaccines as effective therapies
